Israele - ebraico - Ministry of Health

vetmarket ltd, israel - milbemycin oxime; praziquantel - טבליות מצופות פילם - praziquantel 125 mg; milbemycin oxime 12.5 mg

Israele - ebraico - Ministry of Health

beit-erez havat milatin ltd - afoxolaner; milbemycin oxime - טבליות לעיסות - afoxolaner 150 mg; milbemycin oxime 30 mg

Israele - ebraico - Ministry of Health

beit-erez havat milatin ltd - afoxolaner; milbemycin oxime - טבליות לעיסות - afoxolaner 18.75 mg; milbemycin oxime 3.75 mg

Israele - ebraico - Ministry of Health

beit-erez havat milatin ltd - afoxolaner; milbemycin oxime - טבליות לעיסות - afoxolaner 37.5 mg; milbemycin oxime 7.5 mg

Israele - ebraico - Ministry of Health

beit-erez havat milatin ltd - afoxolaner; milbemycin oxime - טבליות לעיסות - afoxolaner 75 mg; milbemycin oxime 15 mg

Israele - ebraico - Ministry of Health

beit-erez havat milatin ltd - afoxolaner; milbemycin oxime - טבליות לעיסות - afoxolaner 9.375 mg; milbemycin oxime 1.875 mg

Israele - ebraico - Ministry of Health

merck sharp & dohme israel ltd - aprepitant - קפסולות - aprepitant 80 mg - aprepitant - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

Israele - ebraico - Ministry of Health

merck sharp & dohme israel ltd - aprepitant - קפסולות - aprepitant 80 mg - aprepitant - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

Israele - ebraico - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - aprepitant - קפסולות - aprepitant 80 mg - aprepitant - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

Israele - ebraico - Ministry of Health

merck sharp & dohme israel ltd - aprepitant - קפסולות - aprepitant 125 mg - aprepitant - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.